Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial
Satoshi Ebata, Ayumi Yoshizaki, Koji Oba, Kosuke Kashiwabara, Keiko Ueda, Yukari Uemura, Takeyuki Watadani, Takemichi Fukasawa, Shunsuke Miura, Asako Yoshizaki‐Ogawa, Naoko Okiyama, Masanari Kodera, Minoru Hasegawa, Shinichi Sato
Topics & Concepts
MedicinePlaceboRituximabClinical endpointRheumatismInternal medicineClinical trialRheumatologyOpen labelDouble blindPhysical therapySurgeryLymphomaPathologyAlternative medicineSystemic Sclerosis and Related DiseasesMultiple Sclerosis Research StudiesDupuytren's Contracture and Treatments